• Info
  • Insider Ownership

Insider Trading & Ownership of Eddie Williams

Location
South San Francisco, CA
Summary
The estimated net worth of Eddie Williams is at least $39,836 dollars as of 18 Jun 2025. Eddie Williams is the Director of BioAtla, Inc. and owns shares of BioAtla, Inc. (BCAB) stock worth about $23.5K. Eddie Williams is the Director of CATALYST BIOSCIENCES, INC. and owns shares of GYRE THERAPEUTICS, INC. (GYRE) stock worth about $16.4K.
Signature
/s/ Christian Vasquez, as Attorney-in-Fact for Eddie Williams
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Eddie Williams and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Eddie Williams has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $39,836.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: BioAtla, Inc. ($23,478).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Eddie Williams

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BCAB BioAtla, Inc. Director $23,478 18 Jun 2025
GYRE CATALYST BIOSCIENCES, INC. Director $16,358 07 Jan 2022
PHGE BiomX Inc. Director 14 Apr 2025

Insider Transactions Reported by Eddie Williams:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored